Skip to content
  • CAT
  • ESP
  • ENG
  • About us
  • Contact
El·lipse
  • instagram
  • twitter
  • flickr
  • linkdin
  • facebook
  • youtube
  • Research
  • Public engagement
  • Scientific life
  • Community
  • About us
  • Contact
  • instagram
  • twitter
  • flickr
  • linkdin
  • facebook
  • youtube
  • CAT
  • ESP
  • ENG

Immunology

17.04.2023

Pollution worsens the efficiency of Covid-19 vaccines

04.11.2022

Individualized follow-up of COVID-19 vaccine for some HIV patients

29.09.2022

Immune response protein is involved in embryonic development

17.04.2022

A step closer to personalising multiple sclerosis treatment

17.11.2021

Discovered a new mechanism against Epstein-Barr virus infection

Two hands with a white globe, collide
25.08.2021

Antibodies against SARS-CoV-2 remain stable seven months after the infection

12.07.2021

Immunity anniversary: antibodies against SARS-CoV-2 remain one year after infection

04.03.2021

Launched a clinical trial to prevent the side effects of COVID-19

02.12.2020

SARS-Cov-2 antibodies detected three months after the infection

The last "IMIM Seminars At Home" presented two of the Covid19 projects taking place at the IMIM. One focuses on drug development, the other relies on the immune response.
22.05.2020

Drugs and antibodies: the strategies of two IMIM groups to block SARS-CoV-2

Patients who received redemsivir had a 31% faster recovery time than those who received placebo. There was a 4-day reduction in hospital stay. | Picture by Francisco Avia.
08.05.2020

The antiviral drug remdesivir reduces the time to recovery in COVID-19 patients

60-90% of the adult world population is infected by cytomegalovirus. It is a latent and asymptomatic infection. | Picture by Qimono from Pixabay.
27.02.2020

New protection biomarker against cytomegalovirus in kidney transplant patients

El·lipse is published by the PRBB Communications and Corporate Relations Area.

Dr Aiguader, 88, 08003 Barcelona, Spain

For any suggestions or collaborations please contact us at ellipse@prbb.org

  • Read past print editions
  • About El·lipse
  • About the PRBB
  • Legal disclaimer
  • instagram
  • twitter
  • flickr
  • linkdin
  • facebook
  • youtube
© 2023 El·lipse, PRBB
  • Home
  • News
  • Our picks
This website uses cookies that provide us with personal information, such as data associated with your browsing. If you click on I AGREE, both we and our Partners can install cookies or access non-sensitive information on your device in order to facilitate the reproduction of content, provide features on social networks, create profiles and compile statistics on traffic and usability in our website. You can get MORE INFORMATION by accessing our COOKIES POLICY. I agree More information
Privacy & Cookies Policy
Necessary Always Enabled

Subscribe to our mailing list
Want to be the first to know everything that goes on at the biggest biomedical research hub in Southern Europe? Subscribe to the el·lipse newsletter!

We will send you an email with the latest news.

See you soon!

You are subscribing to receive the newsletter in English. If you would like to receive it in Catalan or Spanish, please change the language settings in our web.

PRBB will use the information you provide on this form to be in touch with you and to provide updates. By clicking below to subscribe, you accept our privacy policy. You can unsubscribe at any time.